查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2087694

獸用和動物疫苗市場：2026-2032年全球市場預測（按產品類型、給藥途徑、目標疾病、技術平台、價態、動物種類、分銷管道和最終用戶分類）

Veterinary/Animal Vaccines Market by Product Type, Route Of Administration, Disease Indication, Technology Platform, Valency, Animal Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸藥和動物疫苗市場將成長至 240.1 億美元，複合年成長率為 6.89%。

主要市場統計數據
基準年 2025 150.5億美元
預計年份：2026年 160.5億美元
預測年份 2032 240.1億美元
複合年成長率 (%) 6.89%

獸用和動物疫苗是動物預防醫學、食品安全和通用感染疾病控制的基石。它們能降低牲畜和伴侶動物的發病率和死亡率，透過減少抗生素的使用來支持抗菌藥物的合理使用，並有助於在感染疾病爆發可能導致流動限制、撲殺和出口禁令的地區維持貿易的連續性。

全球對安全動物性蛋白質的需求不斷成長、生物安全要求日益嚴格、寵物數量不斷增加以及政府主導的疾病控制計劃，共同塑造了疫苗市場需求。主要疫苗類別包括減毒活疫苗、去活化疫苗、類毒素疫苗、次單位疫苗疫苗、重組疫苗、載體疫苗、DNA疫苗以及新興的RNA平台疫苗，這些疫苗廣泛應用於牛、豬、家禽、水產養殖、馬匹和寵物健康管理等領域。

獸用疫苗市場日益注重速度、準確性和擴充性。製造商和動物健康相關人員正在投資研發耐熱多價疫苗、能夠區分感染動物和接種動物的DIVA反應型疫苗，以及能夠快速適應新變種和新興病原體出現的平台技術。

動物疫苗領域的變革性變化

動物疫苗的格局正從疫情爆發後的被動應對轉向綜合疾病預防。各國政府、生產商、獸醫和製藥公司正在將疫苗接種與監測、診斷、生物安全和可追溯性聯繫起來。這種轉變在口蹄疫、禽流感、非洲豬瘟以及狂犬病、布氏桿菌症和小反芻動物鼠疫等跨國動物疫病的研究計畫中尤為明顯。

人工智慧對獸用疫苗的累積影響

人工智慧 (AI) 正在改變獸用疫苗的發現、研發、生產和應用方式。在研發階段，AI 驅動的生物資訊學可以幫助識別候選抗原、比較病原體基因組、追蹤突變以及進行表位定位。這些功能對於快速進化的病原體以及需要根據監測數據更新病毒株的疫苗尤其重要。

主要區域洞察：亞太地區、北美地區、拉丁美洲地區、歐洲地區、中東和非洲地區

亞太地區因其龐大的牲畜存欄量、蓬勃發展的家禽和水產養殖業以及對疾病防治基礎設施的持續投入，成為重點關注區域。中國和印度是區域需求的核心，這得益於其大規模的動物性蛋白質生產、乳製品產業的發展以及政府主導的疫苗接種計劃。同時，日本、韓國和澳洲則高度重視生物安全標準、伴侶動物福利以及先進的生技藥品監管體系。

主要集團概況：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

東協的需求主要來自家禽、生豬、​​水產養殖和小規模畜牧養殖系統，這些系統需要可擴展的疫苗接種模式、更完善的低溫運輸以及適應當地情況的疾病監測系統。海灣合作理事會則專注於生物安全、食品進口韌性以及駱駝、綿羊、山羊、家禽和伴侶動物的疫苗接種需求，其中公共部門採購在動物健康規劃中仍然發揮著至關重要的作用。

對主要獸用疫苗市場關鍵國家的洞察

美國憑藉先進的生技藥品監管、強勁的寵物保健需求和完善的畜牧業健康計劃，在生物製品市場佔據領先地位。加拿大則受益於其高標準的動物健康體係以及北美地區跨境畜牧業貿易的協調運作。墨西哥是重要的畜禽市場，疫苗接種有助於提高生產力、控制狂犬病並為出口做好準備。巴西是世界領先的動物性蛋白質生產國之一，牛、家禽和豬的疫苗對於疾病預防、生物安全和市場進入至關重要。

為獸用疫苗產業領導者提供的實用建議

產業領導者應優先考慮基於平台的疫苗研發、加強監測系統夥伴關係以及提高生產柔軟性。重組疫苗、載體疫苗和核酸疫苗平台可以提高反應速度，但它們的成功取決於已證實的有效性、清晰的監管路徑和可擴展的品管系統。

獸用和動物疫苗分析的調查方法

本執行摘要採用以二手資料主導基礎的調查方法編寫，符合市場情報的最佳實務。資訊來源動物衛生監管機構、獸醫機構、政府間組織、科學文獻、產品核可、疾病管制計畫、疫苗接種指南以及貿易相關的生物安全框架等公開資訊。

結論：獸用疫苗是「同一健康」理念的成長引擎

隨著全球蛋白質需求不斷成長，通用感染疾病風險、抗生素抗藥性以及動物疾病爆發帶來的經濟影響日益凸顯，獸用和動物疫苗的戰略重要性也日益凸顯。該領域正從傳統的疫苗接種模式轉向數據驅動、平台驅動和在地化最佳化的預防策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用與動物疫苗市場：依產品類型分類

  • 減毒活疫苗
  • 去活化疫苗
  • 次單位疫苗和重組疫苗
  • 病毒載體疫苗

第8章 獸用及動物疫苗市場：依給藥途徑分類

  • 腸外
  • 口服
  • 外用

第9章 獸用與動物疫苗市場：依疾病適應症分類

  • 病毒性疾病
    • 狂犬病
    • 口蹄疫
    • 新城疫
    • 犬小病毒
    • 犬瘟熱
    • 貓泛白血球減少症
    • 傳染性牛鼻氣管炎
  • 細菌性疾病
    • 布氏桿菌症
    • 鉤端螺旋體病
    • 梭狀菌感染
    • 巴氏桿菌症
    • 大腸桿菌感染
  • 寄生蟲病
  • 黴菌感染疾病

第10章 獸用及動物疫苗市場：依技術平台分類

  • 傳統疫苗
  • 先進疫苗
  • 新型配送系統

第11章 獸用與動物疫苗市場：依價態分類

  • 疫苗單價
  • 多價疫苗

第12章 獸用與動物疫苗市場：依動物類型分類

  • 伴侶動物
    • 狗
    • 貓
    • 馬
  • 肉類動物
    • 牛
    • 豬
    • 家禽
    • 綿羊和山羊
    • 水產養殖
  • 野生動物和動物園動物

第13章 獸用及動物疫苗市場：依通路分類

  • 動物診所
  • 零售藥房
  • 網路藥房

第14章 獸用與動物疫苗市場：依最終用戶分類

  • 獸醫醫院和診所
  • 畜牧場及生產設施
  • 參考實驗室
  • 研究機構和大學
  • 政府和公共衛生機構

第15章 獸用及動物疫苗市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 獸用及動物疫苗市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 獸藥與動物疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Arko Corp.
  • Bimeda Biologicals Inc
  • Biogenesis Bago SA
  • Biogenesis Bago SA
  • Bioveta, as
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Limited
  • Hipra SA
  • Huvepharma, Inc.
  • Indian Immunologicals Limited
  • Jinyu Bio-technology Co., Ltd.
  • Kemin Industries, Inc.
  • Merck & Co., Inc.
  • MEVAC
  • Neogen Corporation
  • Nisseiken Co., Ltd.
  • Pfizer, Inc.
  • Phibro Animal Health Corporation
  • Qingdao Yebio Biological Engineering Co., Ltd.
  • SAN Group
  • Seppic by Air Liquide Healthcare
  • SK Bioscience
  • Vaxxinova
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-034B500303A8

The Veterinary/Animal Vaccines Market is projected to grow by USD 24.01 billion at a CAGR of 6.89% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.05 billion
Estimated Year [2026] USD 16.05 billion
Forecast Year [2032] USD 24.01 billion
CAGR (%) 6.89%

Veterinary and animal vaccines are a foundational pillar of preventive animal health, food security, and zoonotic disease control. They reduce morbidity and mortality in livestock and companion animals, support antimicrobial stewardship by lowering disease-driven antibiotic use, and help protect trade continuity in sectors where outbreaks can trigger movement restrictions, culling, and export bans.

Demand is being shaped by the rising global need for safe animal protein, intensifying biosecurity requirements, expanding companion animal ownership, and government-backed disease control programs. Core vaccine categories include live attenuated, inactivated, toxoid, subunit, recombinant, vector-based, DNA, and emerging RNA platforms used across cattle, swine, poultry, aquaculture, equine, and pet health applications.

The veterinary vaccines market is increasingly defined by speed, precision, and scalability. Manufacturers and animal health stakeholders are investing in thermostability, multivalent formulations, DIVA-compatible vaccines that help differentiate infected from vaccinated animals, and platform technologies that can be adapted faster when new variants or emerging pathogens appear.

Transformative Shifts in the Animal Vaccine Landscape

The veterinary vaccines landscape is moving from reactive outbreak response toward integrated disease prevention. Governments, producers, veterinarians, and pharmaceutical organizations are aligning vaccination with surveillance, diagnostics, biosecurity, and traceability. This shift is especially visible in transboundary animal diseases such as foot-and-mouth disease, avian influenza, African swine fever research programs, rabies, brucellosis, and peste des petits ruminants.

Another major shift is the growing importance of species-specific and production-system-specific immunization. Poultry and swine operations require high-volume, cost-efficient vaccination supported by hatchery automation and herd-level protocols, while cattle and aquaculture programs increasingly emphasize disease economics, regional pathogen pressure, and cold-chain reliability. In companion animal health, preventive vaccination remains central to veterinary practice as pet ownership rises and owners seek longer, healthier animal lifespans.

Innovation is also transforming competitive positioning. Recombinant and vector vaccines are gaining relevance where conventional approaches face safety, efficacy, or differentiation challenges. At the same time, regulatory expectations for potency, safety, pharmacovigilance, and manufacturing consistency are raising barriers to entry and rewarding participants with proven quality systems.

Cumulative Impact of Artificial Intelligence on Veterinary Vaccines

Artificial intelligence is beginning to reshape veterinary vaccine discovery, development, manufacturing, and field deployment. In research, AI-enabled bioinformatics can help identify antigen candidates, compare pathogen genomes, track mutations, and support epitope mapping. These capabilities are particularly relevant for rapidly evolving pathogens and for vaccines requiring strain updates based on surveillance data.

In clinical development and production, machine learning can improve trial design, batch analytics, quality monitoring, and yield optimization. AI tools also support predictive epidemiology by integrating farm-level, climate, movement, and diagnostic data to identify disease risk patterns. This can help animal health stakeholders prioritize vaccination campaigns and optimize inventory allocation.

The cumulative impact is not replacement of scientific validation, but acceleration of evidence generation. Veterinary vaccines still require controlled studies, regulatory review, safety monitoring, and real-world effectiveness data. However, AI can shorten decision cycles and improve precision when paired with validated diagnostics, robust datasets, and responsible governance.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority region due to its large livestock population, major poultry and aquaculture industries, and continued investment in disease control infrastructure. China and India are central to regional demand, supported by large-scale animal protein production, dairy development, and government vaccination initiatives, while Japan, South Korea, and Australia emphasize high biosecurity standards, companion animal care, and advanced biologics oversight.

North America remains a mature and innovation-led region, supported by strong veterinary infrastructure, high companion animal spending, established livestock vaccination programs, and rigorous oversight from public veterinary biologics authorities in the United States and Canada. Latin America is closely tied to cattle, poultry, and swine production, with Brazil and Mexico playing important roles in commercial vaccination, rabies prevention, and export-oriented disease control.

Europe is shaped by stringent quality, pharmacovigilance, animal welfare, and food safety frameworks, with regional harmonization influencing regulatory access and post-authorization monitoring. The Middle East is increasing attention to livestock resilience, camel and small ruminant health, poultry biosecurity, and import controls, particularly in Gulf economies. Africa has substantial unmet need, with vaccination programs central to controlling diseases that affect pastoral livelihoods, food security, and zoonotic risk, including rabies, peste des petits ruminants, and other transboundary animal diseases.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN demand is supported by poultry, swine, aquaculture, and smallholder livestock systems that require scalable vaccination models, stronger cold chains, and regionally adapted disease surveillance. The GCC is focused on biosecurity, food import resilience, and vaccination needs for camels, sheep, goats, poultry, and companion animals, with public-sector procurement remaining important in animal health planning.

The European Union is a benchmark for regulatory quality, pharmacovigilance, traceability, and One Health alignment. Policy priorities around antimicrobial resistance and animal welfare reinforce the value of preventive immunization. BRICS countries represent a large share of global livestock production and animal protein consumption, making them strategically important for volume-based adoption, local manufacturing, technology transfer, and government-backed immunization programs.

The G7 countries lead in research intensity, premium companion animal care, advanced biologics manufacturing, and high-standard regulatory science, while NATO member countries share heightened attention to biosecurity, supply-chain resilience, and preparedness for animal disease events that could disrupt food systems. Across all groups, veterinary vaccines are increasingly viewed as strategic infrastructure rather than discretionary animal health products.

Key Country Insights Across Major Veterinary Vaccine Markets

The United States leads through advanced biologics regulation, strong pet healthcare demand, and integrated livestock health programs, while Canada benefits from high animal health standards and cross-border alignment in North American livestock trade. Mexico is a significant livestock and poultry market where vaccination supports productivity, rabies control, and export readiness. Brazil is one of the world's most important animal protein producers, making cattle, poultry, and swine vaccines essential to disease prevention, biosecurity, and market access.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature veterinary networks with strong companion animal care and livestock disease prevention programs. Germany and France are also important centers for animal health research, quality systems, and biologics expertise. Russia's large livestock base creates demand for domestically supplied and regionally adapted vaccines, particularly for cattle, poultry, and swine.

China and India are pivotal because of livestock scale, poultry expansion, dairy development, aquaculture relevance, and government-led disease control priorities. Japan, Australia, and South Korea are characterized by high biosecurity expectations, technologically advanced veterinary services, and strong demand for quality-assured biologics. Australia's livestock export orientation and recognized disease-free status for several major pathogens make preventive animal health, quarantine systems, and surveillance especially important.

Actionable Recommendations for Veterinary Vaccine Industry Leaders

Industry leaders should prioritize platform-based vaccine development, stronger surveillance partnerships, and manufacturing flexibility. Recombinant, vector, and nucleic acid platforms can improve response speed, but success depends on validated efficacy, clear regulatory pathways, and scalable quality systems.

Organizations should localize strategies by species, disease burden, production model, and purchasing channel. High-volume livestock markets require affordability, reliability, and distribution strength, while companion animal markets reward veterinary trust, professional education, and clear owner communication.

Recommended actions include investing in thermostable formulations, expanding DIVA and multivalent portfolios, strengthening cold-chain visibility, using AI for surveillance-linked portfolio planning, and partnering with governments, universities, and producer organizations. Leaders should also integrate vaccine programs with diagnostics, biosecurity, and antimicrobial stewardship to demonstrate measurable value beyond product sales.

Research Methodology for Veterinary and Animal Vaccines Analysis

This executive summary is developed using a secondary research-led methodology aligned with market intelligence best practices. Inputs include publicly available information from animal health regulators, veterinary authorities, intergovernmental organizations, scientific literature, product approvals, disease control programs, vaccination guidelines, and trade-relevant biosecurity frameworks.

The analysis applies triangulation across demand drivers, disease epidemiology, regulatory structures, species-level use cases, technology platforms, and regional production systems. Emphasis is placed on verified themes rather than unsupported market sizing claims, ensuring that insights remain credible for strategic planning, market education, and executive decision-making.

Key assessment dimensions include vaccine type, route of administration, target species, disease area, end-user channel, regional policy environment, manufacturing capability, competitive innovation, and adoption constraints such as cold chain, cost, awareness, and field effectiveness.

Conclusion: Veterinary Vaccines as a One Health Growth Engine

Veterinary and animal vaccines are becoming more strategically important as the world confronts rising protein demand, zoonotic disease risk, antimicrobial resistance, and the economic impact of animal disease outbreaks. The sector is advancing from conventional vaccination models toward data-informed, platform-enabled, and regionally tailored prevention strategies.

Future progress will depend on scientific innovation, regulatory trust, field-proven efficacy, and equitable access. Organizations that combine strong biologics expertise with AI-enabled surveillance, resilient supply chains, and deep regional partnerships will be best positioned to address opportunities across livestock, aquaculture, and companion animal health.

As prevention becomes central to animal health economics and One Health policy, veterinary vaccines will remain a critical enabler of productivity, food security, trade stability, and public health protection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary/Animal Vaccines Market, by Product Type

  • 7.1. Live Attenuated Vaccines
  • 7.2. Inactivated Vaccines
  • 7.3. Subunit & Recombinant Vaccines
  • 7.4. Viral Vector Vaccines

8. Veterinary/Animal Vaccines Market, by Route Of Administration

  • 8.1. Parenteral
  • 8.2. Oral
  • 8.3. Topical

9. Veterinary/Animal Vaccines Market, by Disease Indication

  • 9.1. Viral Diseases
    • 9.1.1. Rabies
    • 9.1.2. Foot-and-Mouth Disease
    • 9.1.3. Newcastle Disease
    • 9.1.4. Canine Parvovirus
    • 9.1.5. Canine Distemper
    • 9.1.6. Feline Panleukopenia
    • 9.1.7. Infectious Bovine Rhinotracheitis
  • 9.2. Bacterial Diseases
    • 9.2.1. Brucellosis
    • 9.2.2. Leptospirosis
    • 9.2.3. Clostridial Infections
    • 9.2.4. Pasteurellosis
    • 9.2.5. Colibacillosis
  • 9.3. Parasitic Diseases
  • 9.4. Fungal Infections

10. Veterinary/Animal Vaccines Market, by Technology Platform

  • 10.1. Conventional Vaccines
  • 10.2. Advanced Vaccines
  • 10.3. Novel Delivery Systems

11. Veterinary/Animal Vaccines Market, by Valency

  • 11.1. Monovalent Vaccines
  • 11.2. Multivalent Vaccines

12. Veterinary/Animal Vaccines Market, by Animal Type

  • 12.1. Companion Animals
    • 12.1.1. Dogs
    • 12.1.2. Cats
    • 12.1.3. Horses
  • 12.2. Food-Producing Animals
    • 12.2.1. Cattle
    • 12.2.2. Swine
    • 12.2.3. Poultry
    • 12.2.4. Sheep & Goats
    • 12.2.5. Aquaculture
  • 12.3. Wildlife & Zoo Animals

13. Veterinary/Animal Vaccines Market, by Distribution Channel

  • 13.1. Veterinary Clinics
  • 13.2. Retail Pharmacies
  • 13.3. Online Pharmacies

14. Veterinary/Animal Vaccines Market, by End User

  • 14.1. Veterinary Hospitals & Clinics
  • 14.2. Animal Farms & Production Units
  • 14.3. Reference Laboratories
  • 14.4. Research Institutes & Universities
  • 14.5. Government & Public Health Agencies

15. Veterinary/Animal Vaccines Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Veterinary/Animal Vaccines Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Veterinary/Animal Vaccines Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Arko Corp.
  • 19.2. Bimeda Biologicals Inc
  • 19.3. Biogenesis Bago S.A.
  • 19.4. Biogenesis Bago S.A.
  • 19.5. Bioveta, a.s.
  • 19.6. Boehringer Ingelheim International GmbH
  • 19.7. Ceva Sante Animale
  • 19.8. Dechra Pharmaceuticals PLC
  • 19.9. Elanco Animal Health Incorporated
  • 19.10. Endovac Animal Health
  • 19.11. Hester Biosciences Limited
  • 19.12. Hipra S.A.
  • 19.13. Huvepharma, Inc.
  • 19.14. Indian Immunologicals Limited
  • 19.15. Jinyu Bio-technology Co., Ltd.
  • 19.16. Kemin Industries, Inc.
  • 19.17. Merck & Co., Inc.
  • 19.18. MEVAC
  • 19.19. Neogen Corporation
  • 19.20. Nisseiken Co., Ltd.
  • 19.21. Pfizer, Inc.
  • 19.22. Phibro Animal Health Corporation
  • 19.23. Qingdao Yebio Biological Engineering Co., Ltd.
  • 19.24. SAN Group
  • 19.25. Seppic by Air Liquide Healthcare
  • 19.26. SK Bioscience
  • 19.27. Vaxxinova
  • 19.28. Virbac S.A.
  • 19.29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VIRAL DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIRAL DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIRAL DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RABIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RABIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RABIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANINE DISTEMPER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CANINE DISTEMPER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANINE DISTEMPER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRUCELLOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRUCELLOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRUCELLOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PASTEURELLOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PASTEURELLOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PASTEURELLOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COLIBACILLOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COLIBACILLOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COLIBACILLOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ADVANCED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ADVANCED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ADVANCED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 247. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 248. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 250. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 251. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 255. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 286. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 287. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 289. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 290. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 299. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 300. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 301. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 302. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 303. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 326. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 327. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 331. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 334. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 339. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 340. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 341. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 342. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 343. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2018-2032 (USD MILLION)
  • TABLE 344. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 346. MEXICO VETERINARY/ANIMAL